StockNews.AI
WGS
StockNews.AI
182 days

GeneDx Reports Fourth Quarter and Full Year 2024 Financial Results and Issues Guidance for Full Year 2025

1. GeneDx Holdings reports Q4 and full year 2024 financial results. 2. Future growth may depend on emerging market demands for genetic testing.

+41.09%Current Return
VS
+0.23%S&P 500
$76.3502/18 06:23 AM EDTEvent Start

$107.7202/19 01:09 PM EDTLatest Updated
2m saved
Insight
Article

FAQ

Why Bullish?

Positive financial results can enhance investor confidence, similar to past performance spikes.

How important is it?

Strong financial results directly influence stock value and investor perception.

Why Short Term?

Immediate investor reactions could boost stock price based on quarterly results.

Related Companies

GAITHERSBURG, Md.--(BUSINESS WIRE)--GeneDx Holdings Corp. (Nasdaq: WGS) today reported its financial results for the fourth quarter and full year of 2024.

Related News